Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes

Nephron

Volumn 74, Issue 1, 1996, Pages 136-143

  Mattar, Ana L ^a   Fujihara, Clarice K ^a   Ribeiro, Miriam O ^a   De Nucci, Gilberto ^b   Zatz, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Endothelium derived relaxing factor; Experimental diabetes; Glomerular filtration rate; Kidney; Renal hemodynamics

Indexed keywords

ANGIOTENSIN; DRINKING WATER; ENDOTHELIN 1; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; MALE; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; ULTRAFILTRATION; URINARY EXCRETION; VASOCONSTRICTION;

EID: 0029782114     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189293     Document Type: Article

References (33)

1. Stalder G, Schmid R: Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Paediatr 1959;193:129-138.
2. Hostetler TH. Troy JL. Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981:19:410-415.
3. Kasiske BL, O'Donnel MP. Keane WF: Glucose-induced increases in renal hemodynamic function. Possible modulation by renal prostaglandins. Diabetes 1985:34:360-364.
4. Ortola FV, Ballermann BJ. Anderson S. Mendez RE. Brenner BM: Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest 1987:80:670-674.
5. Hirschberg R. Rabb H. Bergamo R. Kopple JD: The delayed effect of growth hormone on renal function in humans. Kidnev Int 1989;35: 865-870.
6. Harvey JN. Edmundson AW. Jaffa AA. Martin EL, Mayfield RK: Renal excretion of kallikrein and eicosanoids in patients with type I (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabcto-logia 1992:35:857-862.
7. Ballermann BJ. Skorccki KL. Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 1984;247:F110-F116.
8. Palmer RMJ. Rees DD. Ashton DS. Moncada S: β-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Comm 1988:153:1251-1256.
9. Rees DD. Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989:86:3375-3378.
10. Baylis C. Mitruka B. Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992:90:278-281.
11. Zatz R. De-Nucci G: Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 1991;261:F360-F363.
12. Ribciro MO, Antuncs E. De-Nucci G. Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 1992;20:298-303.
13. Amal JF. Warin L. Michel JB: Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992;90: 647-652.
14. Bank N. Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993:43:1306-1312.
15. Tolins JP. Shultz PJ. Raij L, Brown DM, Mauer SM: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Am J Physiol 1993: 265:F886-F895.
16. Maddox DA. Price DC, Rector FC Jr: Effects of surgery on plasma volume and salt and water excretion in rats. Am J Physiol 1977:233: F600-F606.
17. Conrad KP. JolTe GM. Kruszyna H. Kruszyna R. Rochelle LG. Smith RP. Chavez JE. Mosher MD: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993:7:566-571.
18. Green LC. Wagner DA, Glogowski J. Skipper PL, Wishnok JS. Tannenbaum SR: Analysis of nitrate, nitrite and [l5N]nitratc in biological fluids. Anal Biochem 1982;126:131-138.
19. Bauer JA, Fung HL: Photochemical generation of nitric oxide from nitro-containing compounds: Possible relation to vascular photorelaxation phenomena. LifeSci 1994;54:1-4.
20. Wallenstein S. Zucker CI, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980:41:1-9.
21. Fujihara CK. Padilha RM. Zatz R: Glomerular abnormalities in long-term experimental diabetes: Role of hemodynamic and nohemodv-namic factors and effects of ant hypertensive therapy. Diabetes 1992:41:286-293.
22. Palmer RMI. Ferrigc AG. Moncada S: Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 1987:327:524-526.
23. King AJ. Troy JL, Anderson S, Ncuringer JR. Gunning M. Brenner BM: Nitric oxide: A potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J Am Soc Nephrol 1991:1:1271-1277.
24. Drury PL. Smith GM. Ferriss JB: Increased vasopressor responsiveness to angiotensin II in type 1 (insulin-dependent) diabetic patients without complications. Diabetologia 1984:27: 174-179.
25. Hill MA. Larkins RG: Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am J Physiol 1989:257:H1438-H1445.
26. Ewald U. Tuvemo T: Reduced vascular reactivity in diabetic children and its relation to diabetic control. Acta Paediatr Scand 1985:74: 77-84.
27. Hcbden RA. Bennett T. Gardiner SM: Pressor sensitivities to vasopressin, angiotensin II. Or methoxamine in diabetic rats. Am J Physiol 1987:253:R726-R734.
28. Anderson S. Rennke HG, Garcia DL. Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidnev Int 1989:36:526-536.
29. Bank N. Klose R. Aynedjian HS. Nguyen D. Sablay LB: Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Int 1987:31:898-905.
30. Konters R. Allen TJ. Cooper ME: Rolcofcndo-thclium-dcrived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994:43:1190-1197.
31. Warg Y-X. Brooks DP. Edwards RM: Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am J Physiol 1993;264:R952-R956.
32. Tesfamarian B. Palacino JJ, Weisbrod RM. Cohen RA: Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 1993:21: 205-211.
33. Carney SL, Wong NLM. Dirks JH: Acute effects of streptozotocin diabetes on rat renal function. J Lab Clin Med 1979;93:950-961.